Share Price and Basic Stock Data
Last Updated: November 8, 2025, 5:40 am
| PEG Ratio | -13.56 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Alkyl Amines Chemicals Ltd operates in the organic chemicals segment, focusing on producing amines and their derivatives. For the financial year ending March 2025, the company reported sales of ₹1,572 Cr, reflecting a growth trajectory from ₹1,683 Cr in March 2023, albeit a decline from ₹1,441 Cr in March 2024. Quarterly sales figures have exhibited volatility, with ₹410 Cr recorded in June 2023 and dipping to ₹352 Cr by September 2023. This trend continued into the December quarter of 2023, where sales stood at ₹322 Cr, indicating potential challenges in maintaining consistent demand. The trailing twelve months (TTM) sales stood at ₹1,578 Cr, demonstrating a slight recovery compared to previous quarters. Overall, while the company has shown resilience in sales over the years, the recent quarterly performance suggests a need for strategic adjustments to bolster revenue stability.
Profitability and Efficiency Metrics
Alkyl Amines Chemicals Ltd has maintained a respectable profitability profile, with a net profit of ₹186 Cr reported for the year ending March 2025, compared to ₹229 Cr in March 2023. The operating profit margin (OPM) stood at 19% for the latest fiscal year, consistent with the 19% reported in March 2024. However, the OPM has seen fluctuations in quarterly results, dropping to 14% in September 2023 before recovering to 18% in subsequent quarters. The company has managed to maintain a return on equity (ROE) of 14% and a return on capital employed (ROCE) of 18.7%, indicating efficient capital utilization relative to its earnings. Additionally, the interest coverage ratio (ICR) has remained strong at 25.70x, showcasing the company’s ability to meet its interest obligations comfortably. Despite these positive indicators, the decline in net profit margins may raise concerns about operational efficiency and cost management.
Balance Sheet Strength and Financial Ratios
Alkyl Amines Chemicals Ltd’s balance sheet reflects a robust financial position with total reserves amounting to ₹1,392 Cr against minimal borrowings of ₹6 Cr as of March 2025. This low leverage underscores the company’s strong equity base and financial stability. The price-to-book value (P/BV) ratio stood at 4.58x, suggesting that the stock is priced at a premium compared to its book value, indicative of strong market confidence. The total assets reached ₹1,789 Cr, supported by fixed assets of ₹1,044 Cr and working capital management reflected in a cash conversion cycle (CCC) of 48 days. The company’s efficiency metrics, including a current ratio of 1.91x and a quick ratio of 1.37x, highlight a solid liquidity position, ensuring that it can meet short-term obligations without difficulty. However, the declining trend in ROCE from 28% in March 2023 to 19% in March 2025 could be a focal point for management to address.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Alkyl Amines Chemicals Ltd indicates a stable ownership structure, with promoters holding 72.03% of the equity as of June 2025. This significant promoter stake reflects strong insider confidence in the company’s long-term prospects. Foreign institutional investors (FIIs) have gradually increased their holdings to 3.26%, while domestic institutional investors (DIIs) hold 2.60%, indicating a growing interest from institutional players. The public shareholding stands at 22.11%, with the total number of shareholders recorded at 161,021. This broad base of retail and institutional investors suggests a diversified investor sentiment, although the gradual decline in public shareholding percentage could indicate potential selling pressure. Overall, the composition of the shareholding structure points to a healthy level of investor confidence, although monitoring changes in public sentiment will be crucial.
Outlook, Risks, and Final Insight
Looking ahead, Alkyl Amines Chemicals Ltd faces a mixed outlook. Strengths include its strong financial position, low debt levels, and consistent operational profitability metrics. However, risks such as fluctuating quarterly sales, declining net profit margins, and a decrease in ROCE present potential challenges that could impact growth. The company’s ability to manage costs effectively and stabilize revenue streams will be critical in navigating these challenges. Additionally, the increasing interest from institutional investors is a positive sign for future capital infusion. The management must focus on strategic initiatives to enhance operational efficiency and adapt to market dynamics. Overall, while there are solid foundations for growth, the company must address its efficiency metrics and revenue consistency to sustain investor confidence and ensure long-term success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Alkyl Amines Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 123 Cr. | 345 | 456/255 | 127 | 390 | 0.03 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,920 Cr. | 9,990 | 14,250/8,150 | 57.3 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 37.5 Cr. | 125 | 329/114 | 15.1 | 24.9 | 0.80 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 35.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 256 Cr. | 320 | 385/163 | 19.8 | 94.6 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,377.14 Cr | 1,665.31 | 405.64 | 330.79 | 0.36% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 473 | 409 | 388 | 412 | 410 | 352 | 322 | 357 | 400 | 415 | 371 | 386 | 406 |
| Expenses | 358 | 328 | 319 | 335 | 336 | 304 | 262 | 288 | 321 | 341 | 301 | 318 | 329 |
| Operating Profit | 116 | 81 | 70 | 78 | 74 | 48 | 60 | 69 | 79 | 74 | 71 | 68 | 77 |
| OPM % | 24% | 20% | 18% | 19% | 18% | 14% | 19% | 19% | 20% | 18% | 19% | 18% | 19% |
| Other Income | 4 | 2 | 5 | 2 | 5 | 2 | 5 | 3 | 5 | 9 | 7 | 9 | 8 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 12 | 11 | 11 | 12 | 12 | 13 | 17 | 17 | 18 | 18 | 18 | 18 | 18 |
| Profit before tax | 107 | 71 | 63 | 67 | 66 | 36 | 46 | 53 | 66 | 64 | 59 | 59 | 66 |
| Tax % | 24% | 27% | 27% | 28% | 25% | 25% | 28% | 28% | 26% | 26% | 26% | 22% | 25% |
| Net Profit | 82 | 52 | 46 | 49 | 50 | 27 | 33 | 38 | 49 | 47 | 44 | 46 | 49 |
| EPS in Rs | 16.03 | 10.26 | 8.94 | 9.52 | 9.74 | 5.33 | 6.54 | 7.52 | 9.56 | 9.28 | 8.56 | 9.00 | 9.67 |
Last Updated: August 20, 2025, 2:00 pm
Below is a detailed analysis of the quarterly data for Alkyl Amines Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 406.00 Cr.. The value appears strong and on an upward trend. It has increased from 386.00 Cr. (Mar 2025) to 406.00 Cr., marking an increase of 20.00 Cr..
- For Expenses, as of Jun 2025, the value is 329.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 318.00 Cr. (Mar 2025) to 329.00 Cr., marking an increase of 11.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 77.00 Cr.. The value appears strong and on an upward trend. It has increased from 68.00 Cr. (Mar 2025) to 77.00 Cr., marking an increase of 9.00 Cr..
- For OPM %, as of Jun 2025, the value is 19.00%. The value appears strong and on an upward trend. It has increased from 18.00% (Mar 2025) to 19.00%, marking an increase of 1.00%.
- For Other Income, as of Jun 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 66.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Mar 2025) to 66.00 Cr., marking an increase of 7.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 22.00% (Mar 2025) to 25.00%, marking an increase of 3.00%.
- For Net Profit, as of Jun 2025, the value is 49.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2025) to 49.00 Cr., marking an increase of 3.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 9.67. The value appears strong and on an upward trend. It has increased from 9.00 (Mar 2025) to 9.67, marking an increase of 0.67.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 5:21 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 446 | 476 | 484 | 501 | 616 | 846 | 993 | 1,242 | 1,542 | 1,683 | 1,441 | 1,572 | 1,578 |
| Expenses | 362 | 390 | 393 | 405 | 499 | 682 | 736 | 812 | 1,216 | 1,335 | 1,189 | 1,280 | 1,289 |
| Operating Profit | 85 | 87 | 91 | 95 | 118 | 164 | 257 | 430 | 326 | 348 | 252 | 291 | 289 |
| OPM % | 19% | 18% | 19% | 19% | 19% | 19% | 26% | 35% | 21% | 21% | 17% | 19% | 18% |
| Other Income | 2 | 2 | 2 | 1 | 2 | 4 | 40 | 6 | 14 | 9 | 14 | 30 | 33 |
| Interest | 12 | 10 | 8 | 8 | 8 | 15 | 10 | 6 | 3 | 3 | 4 | 1 | 1 |
| Depreciation | 10 | 11 | 13 | 14 | 16 | 23 | 27 | 29 | 35 | 45 | 59 | 71 | 71 |
| Profit before tax | 65 | 67 | 72 | 74 | 96 | 130 | 260 | 401 | 302 | 309 | 202 | 249 | 249 |
| Tax % | 34% | 32% | 31% | 32% | 33% | 36% | 17% | 26% | 26% | 26% | 26% | 25% | |
| Net Profit | 43 | 45 | 50 | 50 | 64 | 84 | 215 | 295 | 225 | 229 | 149 | 186 | 187 |
| EPS in Rs | 8.41 | 8.91 | 9.77 | 9.87 | 12.61 | 16.42 | 42.21 | 57.91 | 44.04 | 44.75 | 29.12 | 36.39 | 36.51 |
| Dividend Payout % | 19% | 18% | 41% | 20% | 22% | 20% | 19% | 17% | 23% | 22% | 34% | 28% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 4.65% | 11.11% | 0.00% | 28.00% | 31.25% | 155.95% | 37.21% | -23.73% | 1.78% | -34.93% | 24.83% |
| Change in YoY Net Profit Growth (%) | 0.00% | 6.46% | -11.11% | 28.00% | 3.25% | 124.70% | -118.74% | -60.94% | 25.51% | -36.71% | 59.77% |
Alkyl Amines Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 10% |
| 3 Years: | 1% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 0% |
| 3 Years: | -6% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 9% |
| 3 Years: | -11% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 21% |
| 3 Years: | 16% |
| Last Year: | 14% |
Last Updated: September 4, 2025, 10:50 pm
Balance Sheet
Last Updated: June 16, 2025, 12:31 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 130 | 165 | 189 | 235 | 287 | 355 | 526 | 782 | 980 | 1,159 | 1,257 | 1,392 |
| Borrowings | 151 | 135 | 111 | 120 | 181 | 165 | 87 | 47 | 23 | 88 | 3 | 6 |
| Other Liabilities | 98 | 93 | 95 | 147 | 159 | 218 | 160 | 306 | 359 | 335 | 314 | 381 |
| Total Liabilities | 388 | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 | 1,789 |
| Fixed Assets | 155 | 151 | 187 | 220 | 355 | 376 | 423 | 458 | 629 | 719 | 1,089 | 1,044 |
| CWIP | 3 | 31 | 16 | 35 | 18 | 43 | 45 | 138 | 143 | 352 | 36 | 52 |
| Investments | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 30 | 0 | 0 | 0 | 0 |
| Other Assets | 229 | 218 | 201 | 256 | 262 | 328 | 315 | 520 | 600 | 521 | 459 | 693 |
| Total Assets | 388 | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 | 1,789 |
Below is a detailed analysis of the balance sheet data for Alkyl Amines Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,392.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,257.00 Cr. (Mar 2024) to 1,392.00 Cr., marking an increase of 135.00 Cr..
- For Borrowings, as of Mar 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 3.00 Cr. (Mar 2024) to 6.00 Cr., marking an increase of 3.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 381.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 314.00 Cr. (Mar 2024) to 381.00 Cr., marking an increase of 67.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,789.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,584.00 Cr. (Mar 2024) to 1,789.00 Cr., marking an increase of 205.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1,044.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,089.00 Cr. (Mar 2024) to 1,044.00 Cr., marking a decrease of 45.00 Cr..
- For CWIP, as of Mar 2025, the value is 52.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2024) to 52.00 Cr., marking an increase of 16.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 693.00 Cr.. The value appears strong and on an upward trend. It has increased from 459.00 Cr. (Mar 2024) to 693.00 Cr., marking an increase of 234.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,789.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,584.00 Cr. (Mar 2024) to 1,789.00 Cr., marking an increase of 205.00 Cr..
Notably, the Reserves (1,392.00 Cr.) exceed the Borrowings (6.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -66.00 | -48.00 | -20.00 | -25.00 | -63.00 | -1.00 | 170.00 | 383.00 | 303.00 | 260.00 | 249.00 | 285.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 73 | 76 | 68 | 71 | 73 | 66 | 60 | 67 | 66 | 56 | 56 | 54 |
| Inventory Days | 133 | 105 | 92 | 165 | 99 | 88 | 67 | 91 | 76 | 82 | 85 | 75 |
| Days Payable | 79 | 58 | 63 | 120 | 78 | 104 | 57 | 133 | 105 | 84 | 85 | 80 |
| Cash Conversion Cycle | 128 | 123 | 96 | 116 | 94 | 51 | 71 | 25 | 36 | 53 | 56 | 48 |
| Working Capital Days | 96 | 93 | 87 | 84 | 76 | 56 | 54 | 26 | 35 | 28 | 47 | 42 |
| ROCE % | 28% | 26% | 26% | 24% | 25% | 29% | 41% | 56% | 33% | 28% | 16% | 19% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Nifty Smallcap 250 Index Fund | 12,818 | 0.16 | 2.72 | 12,818 | 2025-04-22 17:25:43 | 0% |
| Motilal Oswal Nifty Smallcap 250 Index Fund | 5,849 | 0.16 | 1.24 | 5,849 | 2025-04-22 17:25:43 | 0% |
| Motilal Oswal Nifty 500 Index Fund | 1,439 | 0.02 | 0.31 | 1,439 | 2025-04-22 17:25:43 | 0% |
| Motilal Oswal Nifty Smallcap 250 ETF | 332 | 0.16 | 0.07 | 332 | 2025-04-22 17:25:43 | 0% |
| Motilal Oswal Nifty 500 ETF | 48 | 0.02 | 0.01 | 48 | 2025-04-22 17:25:43 | 0% |
Key Financial Ratios
| Month | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 98.71 | 42.22 | 32.36 | 25.41 | 24.53 |
| Diluted EPS (Rs.) | 98.44 | 42.10 | 32.36 | 25.41 | 24.53 |
| Cash EPS (Rs.) | 109.66 | 51.66 | 39.53 | 31.67 | 30.79 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 262.88 | 185.71 | 151.39 | 125.32 | 102.02 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 262.88 | 185.71 | 151.39 | 125.32 | 102.44 |
| Revenue From Operations / Share (Rs.) | 486.42 | 414.66 | 301.87 | 245.27 | 236.92 |
| PBDIT / Share (Rs.) | 129.11 | 81.65 | 58.94 | 47.16 | 45.83 |
| PBIT / Share (Rs.) | 115.93 | 70.22 | 50.69 | 40.17 | 39.51 |
| PBT / Share (Rs.) | 118.25 | 62.98 | 46.70 | 36.22 | 35.58 |
| Net Profit / Share (Rs.) | 96.48 | 40.22 | 31.28 | 24.67 | 24.48 |
| NP After MI And SOA / Share (Rs.) | 98.63 | 42.18 | 32.33 | 25.39 | 24.51 |
| PBDIT Margin (%) | 26.54 | 19.69 | 19.52 | 19.23 | 19.34 |
| PBIT Margin (%) | 23.83 | 16.93 | 16.79 | 16.37 | 16.67 |
| PBT Margin (%) | 24.30 | 15.18 | 15.47 | 14.76 | 15.01 |
| Net Profit Margin (%) | 19.83 | 9.70 | 10.36 | 10.05 | 10.33 |
| NP After MI And SOA Margin (%) | 20.27 | 10.17 | 10.71 | 10.35 | 10.34 |
| Return on Networth / Equity (%) | 37.51 | 22.71 | 21.35 | 20.25 | 24.02 |
| Return on Capital Employeed (%) | 37.58 | 27.83 | 22.04 | 22.65 | 28.29 |
| Return On Assets (%) | 25.69 | 11.29 | 10.17 | 9.91 | 12.03 |
| Long Term Debt / Equity (X) | 0.08 | 0.20 | 0.35 | 0.25 | 0.21 |
| Total Debt / Equity (X) | 0.08 | 0.34 | 0.48 | 0.39 | 0.47 |
| Asset Turnover Ratio (%) | 1.28 | 1.21 | 1.06 | 1.08 | 1.18 |
| Current Ratio (X) | 1.91 | 1.26 | 1.33 | 1.40 | 1.42 |
| Quick Ratio (X) | 1.37 | 0.83 | 0.85 | 0.70 | 0.93 |
| Inventory Turnover Ratio (X) | 5.03 | 5.05 | 3.29 | 3.00 | 3.90 |
| Dividend Payout Ratio (NP) (%) | 18.23 | 16.58 | 15.45 | 0.00 | 40.76 |
| Dividend Payout Ratio (CP) (%) | 16.08 | 13.04 | 12.31 | 0.00 | 32.41 |
| Earning Retention Ratio (%) | 81.77 | 83.42 | 84.55 | 0.00 | 59.24 |
| Cash Earning Retention Ratio (%) | 83.92 | 86.96 | 87.69 | 0.00 | 67.59 |
| Interest Coverage Ratio (X) | 25.70 | 11.29 | 14.76 | 11.95 | 11.64 |
| Interest Coverage Ratio (Post Tax) (X) | 18.74 | 6.56 | 8.83 | 7.25 | 7.22 |
| Enterprise Value (Cr.) | 2474.74 | 1821.38 | 1383.38 | 1017.13 | 733.06 |
| EV / Net Operating Revenue (X) | 2.49 | 2.15 | 2.25 | 2.03 | 1.52 |
| EV / EBITDA (X) | 9.39 | 10.93 | 11.50 | 10.56 | 7.84 |
| MarketCap / Net Operating Revenue (X) | 2.48 | 2.02 | 2.01 | 1.84 | 1.33 |
| Retention Ratios (%) | 81.76 | 83.41 | 84.54 | 0.00 | 59.23 |
| Price / BV (X) | 4.58 | 4.52 | 4.00 | 3.60 | 3.08 |
| Price / Net Operating Revenue (X) | 2.48 | 2.02 | 2.01 | 1.84 | 1.33 |
| EarningsYield | 0.08 | 0.05 | 0.05 | 0.05 | 0.07 |
After reviewing the key financial ratios for Alkyl Amines Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 20, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 20, the value is 98.71. This value is within the healthy range. It has increased from 42.22 (Mar 19) to 98.71, marking an increase of 56.49.
- For Diluted EPS (Rs.), as of Mar 20, the value is 98.44. This value is within the healthy range. It has increased from 42.10 (Mar 19) to 98.44, marking an increase of 56.34.
- For Cash EPS (Rs.), as of Mar 20, the value is 109.66. This value is within the healthy range. It has increased from 51.66 (Mar 19) to 109.66, marking an increase of 58.00.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 262.88. It has increased from 185.71 (Mar 19) to 262.88, marking an increase of 77.17.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 262.88. It has increased from 185.71 (Mar 19) to 262.88, marking an increase of 77.17.
- For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 486.42. It has increased from 414.66 (Mar 19) to 486.42, marking an increase of 71.76.
- For PBDIT / Share (Rs.), as of Mar 20, the value is 129.11. This value is within the healthy range. It has increased from 81.65 (Mar 19) to 129.11, marking an increase of 47.46.
- For PBIT / Share (Rs.), as of Mar 20, the value is 115.93. This value is within the healthy range. It has increased from 70.22 (Mar 19) to 115.93, marking an increase of 45.71.
- For PBT / Share (Rs.), as of Mar 20, the value is 118.25. This value is within the healthy range. It has increased from 62.98 (Mar 19) to 118.25, marking an increase of 55.27.
- For Net Profit / Share (Rs.), as of Mar 20, the value is 96.48. This value is within the healthy range. It has increased from 40.22 (Mar 19) to 96.48, marking an increase of 56.26.
- For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is 98.63. This value is within the healthy range. It has increased from 42.18 (Mar 19) to 98.63, marking an increase of 56.45.
- For PBDIT Margin (%), as of Mar 20, the value is 26.54. This value is within the healthy range. It has increased from 19.69 (Mar 19) to 26.54, marking an increase of 6.85.
- For PBIT Margin (%), as of Mar 20, the value is 23.83. This value exceeds the healthy maximum of 20. It has increased from 16.93 (Mar 19) to 23.83, marking an increase of 6.90.
- For PBT Margin (%), as of Mar 20, the value is 24.30. This value is within the healthy range. It has increased from 15.18 (Mar 19) to 24.30, marking an increase of 9.12.
- For Net Profit Margin (%), as of Mar 20, the value is 19.83. This value exceeds the healthy maximum of 10. It has increased from 9.70 (Mar 19) to 19.83, marking an increase of 10.13.
- For NP After MI And SOA Margin (%), as of Mar 20, the value is 20.27. This value exceeds the healthy maximum of 20. It has increased from 10.17 (Mar 19) to 20.27, marking an increase of 10.10.
- For Return on Networth / Equity (%), as of Mar 20, the value is 37.51. This value is within the healthy range. It has increased from 22.71 (Mar 19) to 37.51, marking an increase of 14.80.
- For Return on Capital Employeed (%), as of Mar 20, the value is 37.58. This value is within the healthy range. It has increased from 27.83 (Mar 19) to 37.58, marking an increase of 9.75.
- For Return On Assets (%), as of Mar 20, the value is 25.69. This value is within the healthy range. It has increased from 11.29 (Mar 19) to 25.69, marking an increase of 14.40.
- For Long Term Debt / Equity (X), as of Mar 20, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.20 (Mar 19) to 0.08, marking a decrease of 0.12.
- For Total Debt / Equity (X), as of Mar 20, the value is 0.08. This value is within the healthy range. It has decreased from 0.34 (Mar 19) to 0.08, marking a decrease of 0.26.
- For Asset Turnover Ratio (%), as of Mar 20, the value is 1.28. It has increased from 1.21 (Mar 19) to 1.28, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 20, the value is 1.91. This value is within the healthy range. It has increased from 1.26 (Mar 19) to 1.91, marking an increase of 0.65.
- For Quick Ratio (X), as of Mar 20, the value is 1.37. This value is within the healthy range. It has increased from 0.83 (Mar 19) to 1.37, marking an increase of 0.54.
- For Inventory Turnover Ratio (X), as of Mar 20, the value is 5.03. This value is within the healthy range. It has decreased from 5.05 (Mar 19) to 5.03, marking a decrease of 0.02.
- For Dividend Payout Ratio (NP) (%), as of Mar 20, the value is 18.23. This value is below the healthy minimum of 20. It has increased from 16.58 (Mar 19) to 18.23, marking an increase of 1.65.
- For Dividend Payout Ratio (CP) (%), as of Mar 20, the value is 16.08. This value is below the healthy minimum of 20. It has increased from 13.04 (Mar 19) to 16.08, marking an increase of 3.04.
- For Earning Retention Ratio (%), as of Mar 20, the value is 81.77. This value exceeds the healthy maximum of 70. It has decreased from 83.42 (Mar 19) to 81.77, marking a decrease of 1.65.
- For Cash Earning Retention Ratio (%), as of Mar 20, the value is 83.92. This value exceeds the healthy maximum of 70. It has decreased from 86.96 (Mar 19) to 83.92, marking a decrease of 3.04.
- For Interest Coverage Ratio (X), as of Mar 20, the value is 25.70. This value is within the healthy range. It has increased from 11.29 (Mar 19) to 25.70, marking an increase of 14.41.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 20, the value is 18.74. This value is within the healthy range. It has increased from 6.56 (Mar 19) to 18.74, marking an increase of 12.18.
- For Enterprise Value (Cr.), as of Mar 20, the value is 2,474.74. It has increased from 1,821.38 (Mar 19) to 2,474.74, marking an increase of 653.36.
- For EV / Net Operating Revenue (X), as of Mar 20, the value is 2.49. This value is within the healthy range. It has increased from 2.15 (Mar 19) to 2.49, marking an increase of 0.34.
- For EV / EBITDA (X), as of Mar 20, the value is 9.39. This value is within the healthy range. It has decreased from 10.93 (Mar 19) to 9.39, marking a decrease of 1.54.
- For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 2.48. This value is within the healthy range. It has increased from 2.02 (Mar 19) to 2.48, marking an increase of 0.46.
- For Retention Ratios (%), as of Mar 20, the value is 81.76. This value exceeds the healthy maximum of 70. It has decreased from 83.41 (Mar 19) to 81.76, marking a decrease of 1.65.
- For Price / BV (X), as of Mar 20, the value is 4.58. This value exceeds the healthy maximum of 3. It has increased from 4.52 (Mar 19) to 4.58, marking an increase of 0.06.
- For Price / Net Operating Revenue (X), as of Mar 20, the value is 2.48. This value is within the healthy range. It has increased from 2.02 (Mar 19) to 2.48, marking an increase of 0.46.
- For EarningsYield, as of Mar 20, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 19) to 0.08, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alkyl Amines Chemicals Ltd:
- Net Profit Margin: 19.83%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 37.58% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 37.51% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 18.74
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.37
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 49.9 (Industry average Stock P/E: 405.64)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.08
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 19.83%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | 401-407, Nirman Vyapar Kendra, Plot No. 10, Sector 17, New Mumbai Maharashtra 400703 | legal@alkylamines.com http://www.alkylamines.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Yogesh M Kothari | Chairman & Managing Director |
| Mr. Kirat M Patel | Executive Director |
| Mr. Suneet Y Kothari | Executive Director |
| Mr. Premal N Kapadia | Non Executive Director |
| Mr. Rakesh S Goyal | Whole-Time Director (Operations) |
| Mrs. Leja S Hattiangadi | Independent Director |
| Mr. Chandrashekhar R Gupte | Independent Director |
| Mr. Ravi B Kapoor | Independent Director |
| Mr. Ashwin Ramanathan | Independent Director |
| Mrs. Bhavna G Doshi | Independent Director |
FAQ
What is the intrinsic value of Alkyl Amines Chemicals Ltd?
Alkyl Amines Chemicals Ltd's intrinsic value (as of 09 November 2025) is 1584.87 which is 10.86% lower the current market price of 1,778.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 9,092 Cr. market cap, FY2025-2026 high/low of 2,449/1,508, reserves of ₹1,392 Cr, and liabilities of 1,789 Cr.
What is the Market Cap of Alkyl Amines Chemicals Ltd?
The Market Cap of Alkyl Amines Chemicals Ltd is 9,092 Cr..
What is the current Stock Price of Alkyl Amines Chemicals Ltd as on 09 November 2025?
The current stock price of Alkyl Amines Chemicals Ltd as on 09 November 2025 is 1,778.
What is the High / Low of Alkyl Amines Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alkyl Amines Chemicals Ltd stocks is 2,449/1,508.
What is the Stock P/E of Alkyl Amines Chemicals Ltd?
The Stock P/E of Alkyl Amines Chemicals Ltd is 49.9.
What is the Book Value of Alkyl Amines Chemicals Ltd?
The Book Value of Alkyl Amines Chemicals Ltd is 282.
What is the Dividend Yield of Alkyl Amines Chemicals Ltd?
The Dividend Yield of Alkyl Amines Chemicals Ltd is 0.56 %.
What is the ROCE of Alkyl Amines Chemicals Ltd?
The ROCE of Alkyl Amines Chemicals Ltd is 18.7 %.
What is the ROE of Alkyl Amines Chemicals Ltd?
The ROE of Alkyl Amines Chemicals Ltd is 14.0 %.
What is the Face Value of Alkyl Amines Chemicals Ltd?
The Face Value of Alkyl Amines Chemicals Ltd is 2.00.